Natural Biotech Pty Ltd's flagship NMN (β-Nicotinamide Mononucleotide) capsule line is manufactured in South Australia under a contracted research relationship with the University of Adelaide. NMN is a direct precursor to NAD+, a coenzyme central to cellular energy metabolism whose levels decline with age.
The programme is built around an enzyme-catalysed synthesis pathway designed for purity, cost-efficient scale-up and a globally distributable supplement format — manufactured in Australia and distributed internationally.
The longevity and healthy-ageing supplement category has grown rapidly, with NAD+ precursors among the most studied compounds. Reliable, high-purity, cost-effective manufacturing — and the institutional capacity to scale it — is the differentiator between a research molecule and a distributable product.